Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study

被引：0
|
作者：
Elaine M. Dennison
Katrine Hass Rubin
Peter Schwarz
Nicholas C. Harvey
Karen Walker Bone
Cyrus Cooper
Bo Abrahamsen
机构：
[1] Southampton General Hospital,MRC Lifecourse Epidemiology Units
[2] Victoria University of Wellington,Odense Patient data Explorative Network (OPEN), Institute of Clinical Research
[3] University of Southern Denmark,Department of Medicine
[4] Holbæk Hospital,NIHR Southampton Biomedical Research Centre
[5] University of Southampton and University Hospital Southampton,NIHR Musculoskeletal Biomedical Research Unit
[6] University of Oxford,undefined
来源：
Archives of Osteoporosis | 2015年 / 10卷
关键词：
Osteoporosis; Gout; Fracture; Cohort; Allopurinol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study
    Dennison, Elaine M.
    Rubin, Katrine Hass
    Schwarz, Peter
    Harvey, Nicholas C.
    Bone, Karen Walker
    Cooper, Cyrus
    Abrahamsen, Bo
    ARCHIVES OF OSTEOPOROSIS, 2015, 10 (01)
  • [2] GOUT IS ASSOCIATED WITH AN EXCESS RISK OF OSTEOPOROTIC FRACTURE: FINDINGS FROM A DANISH REGISTRY
    Dennison, E. M.
    Rubin, K. Hass
    Harvey, N. C.
    Walker-Bone, K.
    Schwarz, P.
    Cooper, C.
    Abrahamsen, B.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S306 - S306
  • [3] GOUT IS ASSOCIATED WITH AN EXCESS RISK OF OSTEOPOROTIC FRACTURE: FINDINGS FROM A DANISH REGISTRY
    Dennison, E. M.
    Rubin, K. Hass
    Litwic, A.
    Harvey, N. C.
    Schwarz, P.
    Cooper, C.
    Abrahamsen, B.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S667 - S667
  • [4] Use of Thiazolidinediones and Risk of Osteoporotic Fracture: The Danish National Databases
    Bazelier, Marloes
    Gallagher, Arlene
    van Staa, Tjeerd
    Cooper, Cyrus
    Leufkens, Hubert
    Vestergaard, Peter
    De Vries, Frank
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S119 - S120
  • [5] Alendronic acid: prolonged use not associated with excess fracture risk
    Reactions Weekly, 2004, 996-997 (1) : 3 - 3
  • [6] Thiazolidinedione use and osteoporotic fracture risk
    Meier, C.
    Kraenzlin, M. E.
    Bodmer, M.
    Jick, S. S.
    Jick, H.
    Meier, C. R.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S29 - S29
  • [7] Validity of Major Osteoporotic Fracture Diagnoses in the Danish National Patient Registry
    Clausen, Anne
    Moller, Soren
    Skjodt, Michael Kriegbaum
    Lynggaard, Rasmus Bank
    Vinholt, Pernille Just
    Lindberg-Larsen, Martin
    Sondergaard, Jens
    Abrahamsen, Bo
    Rubin, Katrine Hass
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 257 - 266
  • [8] Rate of bone loss is associated with fracture risk: The Study of Osteoporotic Fractures
    De Dios, Krisel
    Ngoc Huynh
    Thach Tran
    Tuan Nguyen
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 350 - 351
  • [9] Chronic proton pump inhibitor use is not associated with an increased risk of osteoporotic fracture
    Targownik, L. E.
    Leslie, W. D.
    Lix, L. M.
    Metge, C. J.
    Prior, H. J.
    Leong, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S118 - S118
  • [10] MORTALITY RISK ASSOCIATED WITH OSTEOPOROTIC FRAGILITY FRACTURE
    Azevedo, S.
    Parente, H.
    Soares, C.
    Ramos Rodrigues, J.
    Guimaraes, F.
    Santos-Faria, D.
    Peixoto, D.
    Tavares-Costa, J.
    Afonso, C.
    Teixeira, F.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S334 - S334
12345